Menu

New treatment that could prove curative for blood cancer patients to be offered by the NHS

Hundreds of people with an aggressive type of blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a potentially curative new treatment option on the NHS, with approval of the drug glofitamab. Glofitamab (also called Columvi®) is to be made available for patients with previously treated DLBCL which is a […]

Read More  on the NHS website.